Nfkb1 Mouse Gene Knockout Kit (CRISPR)

Specifications

Product Data
Format	2 gRNA vectors, 1 GFP-puro donor, 1 scramble control
Donor DNA	GFP-puro
Symbol	Nfkb1
Locus ID	18033
Kit Components	KN310944G1, Nfkb1 gRNA vector 1 in pCas-Guide CRISPR vector, Target Sequence: ATGGCAGACGATGATCCCTA KN310944G2, Nfkb1 gRNA vector 2 in pCas-Guide CRISPR vector, Target Sequence: TTCTTATCCCAAACACACAG KN310944-D, donor DNA containing left and right homologous arms and GFP-puro functional cassette. Homologous arm and GFP-puro sequences (showhide) pUC vector backbone in gray; Left arm sequence in blue; GFP-puro in green; Right arm in violet TGAAGGCCGC TGAGGCTGCT TATATTAATA GCTTGCTAAG TTCAGTAAGT TTGAGACTTT CAGGTTTGAT GTTTTCACTG GTTATTTTTT TAGTGCACTC TTTAGAGTTA CAGAATTTTC ATTGCACTTT GACAAAGGCA GAATGACTCT CACCAGTCCT CACAAGAGGG CAGGGGGTGT CGTTCTATGC CCACTCAAGT GTTATGTAAA ATGGTATCAG GACTTCCTCA GCCTCTCAAC CGAGTCTAGA CAGTCCTAGG ACCATCTCAG AGTTCATGAG AAAAAAAATG CACAAAGTAG AAGTGGCCAC AGGGTTCCAT CTGGACCTGA TTTTTACCCA GAGGTAGGAC CAGCTGTATC AAACCGAGGA CCCTGAGCTT AGCCAAAGGG TTTAGATCCC GTGGTCTCCC TACAATGAGA GGTAGATGCC AAGGAGGTAC AGCACGCATG ATGCCCTCCT ACAGAGGTCT TTTTTGCAGA CATTTGTGGT CCCTGTAGAA ATACAGCCTA GCCCTGCATA TGTGCCAGAG TTGTAGGATC TTTAAGATTC ACTCCAGTGC TACAGCTTTC ATTTCTTGTT CTGTTTTGTA CAGCTTCACC TAGTAACTCA GTATCAAGCA AACCCTAAAT TAGTAAACAC TACTCTTAAT TTATTTTCAG TTTTTCTGTT CTTCCAGAGT TGGAGAGGGC CCTTTCTTAT GTATTTTTGC ATAAAACCGT ATATACTACA TGCCAGAAAG TAGCCACTGA GTCAGTTGTG GTGTTGAAGG TCTGACCCCA GTATTTCATA TGGTGACTGG TATATTAAAA AAATTGCTAT TCAGTGAGAT TTCTAGGGCT GCTATTAACA TCGCTACAAA CCTGGTGACT TGACACAATA GAAGTGTATC CTTTCATAGG TCTGGAGGCA AGAACTCTGA ATTTGGGGCT GGCAGAATAG TTCCCACCTC CTACCACTGC TGGGTGTGTT TAGAGATCCT TGGCATCACA CCAGCCACAG TCTGTTGTTG TGTGGCTTTC CTCCACGTCT TCACACATAC CATCTCCTCT GTCTTAAAAA CACATCACTT TTTGGATGTA GGATCCATCT CTGTCTAGTG TGAATTCATC TTAACATATA TAAAGGCAAA GGCTGCCGTG TCCAAATAAG TCACATGAAG GAGGAGCACT TATGAATTCT GAATATATTT TTTTTCAAAG GE100003, scramble sequence in pCas-Guide vector
Disclaimer	These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process.
Reference Data
RefSeq	NM_008689
Synonyms	NF-kappaB; NF-kappaB1; NF-KB1; p50; p50/p105; p105
Summary	NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. Plays a role in the regulation of apoptosis. Isoform 5, isoform 6 and isoform 7 act as inhibitors of transactivation of p50 NF-kappa-B subunit, probably by sequestering it in the cytoplasm. Isoform 3 (p98) (but not p84 or p105) acts as a transactivator of NF-kappa-B-regulated gene expression. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.[UniProtKB/Swiss-Prot Function]

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.